Concord Medical Services Holdings Stock-Based Compensation Growth & History (CCM)

Concord Medical Services Holdings's stock-based compensation was −$858,000 for fiscal 2022.

View full Concord Medical Services Holdings company overview

Concord Medical Services Holdings annual stock-based compensation history

Concord Medical Services Holdings annual stock-based compensation

Fiscal yearPeriod endedStock-based compensationChangeGrowth
20222022-12-31−$858,000−$3.2M
20212021-12-31$2.3M−$856,000−27.09%
20202020-12-31$3.2M$202,000+6.83%
20192019-12-31$3.0M$1.3M+82.59%
20182018-12-31$1.6M−$169,000−9.45%
20172017-12-31$1.8M$579,000+47.85%
20162016-12-31$1.2M−$38,000−3.04%
20152015-12-31$1.2M$63,000+5.32%
20142014-12-31$1.2M−$269,000−18.50%
20132013-12-31$1.5M−$4,000−0.27%
20122012-12-31$1.5M−$9,000−0.61%
20112011-12-31$1.5M

Concord Medical Services Holdings stock-based compensation trends

Over the last five fiscal years, Concord Medical Services Holdings's stock-based compensation decreased from $1.8M to −$858,000, a change of −$2.6M.

About the metric

What stock-based compensation means

Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.

Calculation and source

SEC-reported stock-based compensation

TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Concord Medical Services Holdings source filings ↗

Community posts

It’s quiet here.

No posts about CCM yet. Start the conversation.

Write the first post